Growth Metrics

Verastem (VSTM) Cash from Operations (QoQ) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Verastem 425.60 Mn 243.93 Mn 15.90 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -73.99%
Dec 31, 2025 17.29%
Sep 30, 2025 -10.88%
Jun 30, 2025 15.55%
Mar 31, 2025 -54.09%
Dec 31, 2024 -5.48%
Sep 30, 2024 13.69%
Jun 30, 2024 2.60%
Mar 31, 2024 4.63%
Dec 31, 2023 -78.92%
Sep 30, 2023 16.65%
Jun 30, 2023 1.88%
Mar 31, 2023 -22.09%
Dec 31, 2022 -10.17%
Sep 30, 2022 -18.81%
Jun 30, 2022 34.16%
Mar 31, 2022 -94.11%
Dec 31, 2021 8.26%
Sep 30, 2021 19.35%
Jun 30, 2021 30.51%
Mar 31, 2021 10.99%
Dec 31, 2020 -148.50%
Sep 30, 2020 298.46%
Jun 30, 2020 33.69%
Mar 31, 2020 8.65%
Dec 31, 2019 -33.66%
Sep 30, 2019 19.67%
Jun 30, 2019 10.60%
Mar 31, 2019 -102.11%
Dec 31, 2018 14.95%
Sep 30, 2018 -118.75%
Jun 30, 2018 54.07%
Mar 31, 2018 -10.46%
Dec 31, 2017 -71.54%
Sep 30, 2017 18.17%
Jun 30, 2017 -35.95%
Mar 31, 2017 -78.97%
Dec 31, 2016 1.11%
Sep 30, 2016 10.04%
Jun 30, 2016 38.17%
Mar 31, 2016 -6.07%
Dec 31, 2015 12.13%
Sep 30, 2015 3.37%
Jun 30, 2015 -2.47%
Mar 31, 2015 -21.46%
Dec 31, 2014 -4.32%
Sep 30, 2014 -6.18%
Jun 30, 2014 6.04%
Mar 31, 2014 -41.73%
Dec 31, 2013 7.87%
Sep 30, 2013 -12.42%
Jun 30, 2013 0.28%
Mar 31, 2013 -6.97%
Dec 31, 2012 12.05%
Sep 30, 2012 -33.49%
Jun 30, 2012 -3.08%
Mar 31, 2012 -20.15%
Dec 31, 2011 4.57%
Sep 30, 2011 -2,535.19%
Jun 30, 2011 81.31%